Unknown

Dataset Information

0

Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.


ABSTRACT: There is an urgent need for new drugs against influenza type A and B viruses due to incomplete protection by vaccines and the emergence of resistance to current antivirals. The influenza virus polymerase complex, consisting of the PB1, PB2 and PA subunits, represents a promising target for the development of new drugs. We have previously demonstrated the feasibility of targeting the protein-protein interaction domain between the PB1 and PA subunits of the polymerase complex of influenza A virus using a small peptide derived from the PA-binding domain of PB1. However, this influenza A virus-derived peptide did not affect influenza B virus polymerase activity. Here we report that the PA-binding domain of the polymerase subunit PB1 of influenza A and B viruses is highly conserved and that mutual amino acid exchange shows that they cannot be functionally exchanged with each other. Based on phylogenetic analysis and a novel biochemical ELISA-based screening approach, we were able to identify an influenza A-derived peptide with a single influenza B-specific amino acid substitution which efficiently binds to PA of both virus types. This dual-binding peptide blocked the viral polymerase activity and growth of both virus types. Our findings provide proof of principle that protein-protein interaction inhibitors can be generated against influenza A and B viruses. Furthermore, this dual-binding peptide, combined with our novel screening method, is a promising platform to identify new antiviral lead compounds.

SUBMITTER: Wunderlich K 

PROVIDER: S-EPMC2759517 | biostudies-literature | 2009

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.

Wunderlich Kerstin K   Mayer Daniel D   Ranadheera Charlene C   Holler Anne-Sophie AS   Mänz Benjamin B   Martin Arnold A   Chase Geoffrey G   Tegge Werner W   Frank Ronald R   Kessler Ulrich U   Schwemmle Martin M  

PloS one 20091020 10


There is an urgent need for new drugs against influenza type A and B viruses due to incomplete protection by vaccines and the emergence of resistance to current antivirals. The influenza virus polymerase complex, consisting of the PB1, PB2 and PA subunits, represents a promising target for the development of new drugs. We have previously demonstrated the feasibility of targeting the protein-protein interaction domain between the PB1 and PA subunits of the polymerase complex of influenza A virus  ...[more]

Similar Datasets

| S-EPMC6204821 | biostudies-literature
| S-EPMC6296753 | biostudies-literature
| S-EPMC8310364 | biostudies-literature
| S-EPMC115057 | biostudies-literature
| S-EPMC3571384 | biostudies-literature
| S-EPMC6414799 | biostudies-literature
| S-EPMC7152910 | biostudies-literature
| S-EPMC4980666 | biostudies-literature
| S-EPMC3022683 | biostudies-literature
| S-EPMC6289448 | biostudies-literature